Protodesnitazene

Protodesnitazene
Identifiers
  • N,N-diethyl-2-[2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H31N3O
Molar mass365.521 g·mol−1
3D model (JSmol)
  • CCCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN(CC)CC
  • InChI=1S/C23H31N3O/c1-4-17-27-20-13-11-19(12-14-20)18-23-24-21-9-7-8-10-22(21)26(23)16-15-25(5-2)6-3/h7-14H,4-6,15-18H2,1-3H3
  • Key:CEHFMRGBRNNSCM-UHFFFAOYSA-N

Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.

See also

References

  1. ↑ Griffiths A, Milne N, Johnston M, Blakey K, Scott R. Protodesnitazene: The identification and tissue distribution of a new nitazene. J Forensic Sci. 2026 Sep 26. doi:10.1111/1556-4029.70478 PMID 42798250
  2. ↑ "High Risk Substance Detected In Fentanyl Trafficking Investigation". Sarnia Police Service. 13 March 2025. Retrieved 17 August 2025.
  3. ↑ "Fredericton Police Warn of New, Potentially Fatal Street Drug". City of Fredericton. Fredericton Police. 9 April 2025. Retrieved 17 August 2025.
  4. ↑ "New nitazene (strong opioid) Protodesnitazene detected" (PDF). Queensland Health. Queensland Government. March 2025. Retrieved 17 August 2025.
  5. ↑ Gwynn L (4 April 2025). "Nitazines found in black market vapes as criminals make new variations to evade detection". ABC News. Australian Broadcasting Corporation. Retrieved 17 August 2025.
  6. ↑ "Rapid Action Drug Alerts and Response (RADAR) Alert: Nitazenes". Public Health Scotland. NHS Scotland. 12 August 2025. Retrieved 17 August 2025.
  7. ↑ "Customs warns about an extremely dangerous substance in the drug trade". Finnish Customs. 20 October 2025. Retrieved 22 August 2025.
  8. ↑ Clayton J, Shi L, Robertson MJ, Skiniotis G, Michaelides M, Stavitskaya L, et al. (August 2025). "A putative binding model of nitazene derivatives at the μ-opioid receptor". Neuropharmacology. 273 110437. doi:10.1016/j.neuropharm.2025.110437. PMC 12279083. PMID 40185362.
  9. ↑ Hardwick EK, Couch AN, Davidson JT (March 2026). "Comparison of Activation Techniques for the Identification of Nitazene Analogs Using the NIST/NIJ Data Interpretation Tool". Rapid Communications in Mass Spectrometry. 40 (5) e70004. doi:10.1002/rcm.70004. PMID 41359886.